ProfileGDS4718 / 230745_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 60% 59% 51% 62% 50% 50% 49% 64% 57% 56% 59% 51% 57% 54% 52% 58% 57% 56% 52% 50% 63% 55% 58% 56% 55% 56% 55% 55% 49% 51% 53% 52% 60% 60% 54% 52% 55% 57% 60% 53% 59% 53% 55% 51% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.0972360
GSM549102patient 115, normal, homogenized [OPG study]6.0773559
GSM549104patient 119, normal, homogenized [OPG study]5.5462751
GSM549108patient 138, normal, homogenized [OPG study]6.2835362
GSM549119patient 077, normal, homogenized [OPG study]5.5236250
GSM549133patient 032, cancer, homogenized [OPG study]5.4430950
GSM549139patient 042, cancer, homogenized [OPG study]5.4417349
GSM549099patient 107, normal, homogenized [OPG study]6.3782664
GSM549109patient 139, normal, homogenized [OPG study]5.9754157
GSM549110patient 046, normal, homogenized [OPG study]5.8890256
GSM549114patient 063, normal, homogenized [OPG study]6.0353759
GSM549122patient 082, normal, homogenized [OPG study]5.6052951
GSM549134patient 033, cancer, homogenized [OPG study]5.9043457
GSM549136patient 036, cancer, homogenized [OPG study]5.724954
GSM549140patient 044, cancer, homogenized [OPG study]5.587552
GSM549111patient 047, normal, homogenized [OPG study]6.0025958
GSM549113patient 057, normal, homogenized [OPG study]5.8901657
GSM549132patient 031, cancer, homogenized [OPG study]5.8336256
GSM549137patient 038, cancer, homogenized [OPG study]5.6023952
GSM549142patient 047, cancer, homogenized [OPG study]5.6180850
GSM549100patient 110, normal, homogenized [OPG study]6.2982863
GSM549107patient 135, normal, homogenized [OPG study]5.7697855
GSM549115patient 068, normal, homogenized [OPG study]5.9652758
GSM549116patient 072, normal, homogenized [OPG study]5.8939456
GSM549120patient 078, normal, homogenized [OPG study]5.79755
GSM549131patient 030, cancer, homogenized [OPG study]5.8026956
GSM549118patient 074, normal, homogenized [OPG study]5.8300455
GSM549129patient 027, cancer, homogenized [OPG study]5.8215355
GSM549123patient 088, normal, homogenized [OPG study]5.4668249
GSM549124patient 006, cancer, homogenized [OPG study]5.5858851
GSM549126patient 015, cancer, homogenized [OPG study]5.6806553
GSM549128patient 025, cancer, homogenized [OPG study]5.6087952
GSM549103patient 117, normal, homogenized [OPG study]6.1487760
GSM549117patient 073, normal, homogenized [OPG study]6.0520760
GSM549138patient 041, cancer, homogenized [OPG study]5.7768254
GSM549141patient 045, cancer, homogenized [OPG study]5.6010752
GSM549130patient 028, cancer, homogenized [OPG study]5.77755
GSM549101patient 111, normal, homogenized [OPG study]5.9553457
GSM549105patient 128, normal, homogenized [OPG study]6.1094960
GSM549106patient 134, normal, homogenized [OPG study]5.6449553
GSM549112patient 048, normal, homogenized [OPG study]6.0692159
GSM549125patient 011, cancer, homogenized [OPG study]5.6791553
GSM549127patient 024, cancer, homogenized [OPG study]5.8424555
GSM549135patient 035, cancer, homogenized [OPG study]5.5401151